Bing

Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. Cyclacel has …
StreetInsider · 5/16/2013
CYCC) this morning at $1.44. Now look at the price of the stock, it’s 40% from our buy call and now at $2.03. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com
Market News Call · 2/27/2015
Likewise, the company entirely liquidated its position in Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC ... signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey. Credit Card is NOT ...
INSIDER MONKEY · 1/17/2014
More from Bing News
5 Best Stocks Under $5 is a feature ... and other serious diseases. CYCC was one of the hottest biotech stocks this week. It recently announced a quarterly dividend of 0.15 per share on their 6% Convertible Exchangeable Preferred stock to stockholders ...
Investor Place · 2/27/2015
CYCC has long been a thorn to many bio-tech investors. The company has struggled to garner significant interest since it's reverse merger with Xcyte Therapies in late 2005 and subsequent Nasdaq listing. As evident below, the stock has performed poorly ...
Seeking Alpha · 3/27/2014
The Company's common stock will continue to trade under the symbol "CYCC." The Company currently meets the NASDAQ Capital Market initial listing criteria, except for the bid price requirement. With the transfer to the NASDAQ Capital Market, the …
Financial Content · 8/11/2015
Also like APPY, though, there's a lot of upside potential here thanks to the sizeable drubbing the stock's seen in 2013. CYCC had been as high as $6.00 in the first quarter of 2013, but hit a low of $2.78 three weeks ago. That's when the tide turned for ...
Smallcap Network · ByBryan Murphy · 7/12/2013
Cyclacel Pharmaceuticals, Inc. (CYCC) is one of Tuesday’s notable stocks in decline ... Over the past 5 trading sessions the stock has lost 3.74%. Shares of Cyclacel Pharmaceuticals, Inc. are down 29.60% year-over-year and 29.60% year-to-date.
Wall Street Pit · 12/16/2014
Related Searches